NanoBio Obtains $11,000,000 Series C Financing Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a3c9d269-9940-4f70-b860-092334c9c7ce&Preview=1
Date 11/29/2012
Company Name NanoBio
Mailing Address 2311 Green Road Ann Arbor, MI 48105
Company Description NanoBio Corporation is a biopharmaceutical company focused on developing and commercializing anti-infective products and mucosal vaccines derived from its patented NanoStat technology platform.
Proceeds Purposes Proceeds from the financing will be used to advance the company’s development programs for herpes labialis (cold sores), cystic fibrosis and nanoemulsion-based vaccines for respiratory syncytial virus (RSV) and genital herpes (HSV2).